BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 16963733)

  • 21. Public health. Creeping consensus on SV40 and polio vaccine.
    Ferber D
    Science; 2002 Oct; 298(5594):725-7. PubMed ID: 12399560
    [No Abstract]   [Full Text] [Related]  

  • 22. Case-control study of cancer among US Army veterans exposed to simian virus 40-contaminated adenovirus vaccine.
    Rollison DE; Page WF; Crawford H; Gridley G; Wacholder S; Martin J; Miller R; Engels EA
    Am J Epidemiol; 2004 Aug; 160(4):317-24. PubMed ID: 15286016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SV40, genetic polymorphism and mesothelioma. pathological and epidemiological evidence.
    Magnani C
    Med Lav; 2005; 96(4):347-53. PubMed ID: 16457431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Childhood exposure to simian virus 40-contaminated poliovirus vaccine and risk of AIDS-associated non-Hodgkin's lymphoma.
    Engels EA; Rodman LH; Frisch M; Goedert JJ; Biggar RJ
    Int J Cancer; 2003 Aug; 106(2):283-7. PubMed ID: 12800207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [SV40: a possible co-carcinogen of asbestos in the pathogenesis of mesothelioma?].
    Cristaudo A; Foddis R; Bigdeli L; Vivaldi A; Buselli R; Guglielmi G; Guidi M; Ottenga F
    Med Lav; 2002; 93(6):499-506. PubMed ID: 12596420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SV40-positive brain tumor in scientist with risk of laboratory exposure to the virus.
    Arrington AS; Moore MS; Butel JS
    Oncogene; 2004 Mar; 23(12):2231-5. PubMed ID: 14676832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40.
    Engels EA; Katki HA; Nielsen NM; Winther JF; Hjalgrim H; Gjerris F; Rosenberg PS; Frisch M
    J Natl Cancer Inst; 2003 Apr; 95(7):532-9. PubMed ID: 12671021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SV40 and SV40-like viruses as possible risk factors.
    Geissler E
    Arch Geschwulstforsch; 1983; 53(3):217-26. PubMed ID: 6311136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re: Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40.
    Puntoni R; Puntoni M; Ceppi M
    J Natl Cancer Inst; 2003 Oct; 95(20):1552-3; author reply 1553-5. PubMed ID: 14559879
    [No Abstract]   [Full Text] [Related]  

  • 30. Simian virus 40, poliovaccines and human tumors: a review of recent developments.
    Carbone M; Rizzo P; Pass HI
    Oncogene; 1997 Oct; 15(16):1877-88. PubMed ID: 9365233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines.
    Strickler HD; Goedert JJ; Devesa SS; Lahey J; Fraumeni JF; Rosenberg PS
    J Natl Cancer Inst; 2003 Jan; 95(1):38-45. PubMed ID: 12509399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thirty-five year mortality following receipt of SV40- contaminated polio vaccine during the neonatal period.
    Carroll-Pankhurst C; Engels EA; Strickler HD; Goedert JJ; Wagner J; Mortimer EA
    Br J Cancer; 2001 Nov; 85(9):1295-7. PubMed ID: 11720463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular evidence of simian virus 40 infections in children.
    Butel JS; Arrington AS; Wong C; Lednicky JA; Finegold MJ
    J Infect Dis; 1999 Sep; 180(3):884-7. PubMed ID: 10438386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virology. Monkey virus link to cancer grows stronger.
    Ferber D
    Science; 2002 May; 296(5570):1012-5. PubMed ID: 12004103
    [No Abstract]   [Full Text] [Related]  

  • 35. An investigation of the occurrence of SV40 antibodies in South Africa.
    Basetse HR; Lecatsas G; Gerber LJ
    S Afr Med J; 2002 Oct; 92(10):825-8. PubMed ID: 12432810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the simian virus SV40 associated with idiopathic focal segmental glomerulosclerosis in humans?
    Galdenzi G; Lupo A; Anglani F; Perini M; Galeazzi L; Giunta S; Marcantoni C; Del Prete D; Graziotto R; D'angelo A; Maschio G; Gambaro G
    J Nephrol; 2003; 16(3):350-6. PubMed ID: 12832733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correspondence re: F. Martini et al., SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res., 56: 4820-4825, 1996.
    Strickler H
    Cancer Res; 1997 Aug; 57(15):3319-20. PubMed ID: 9242467
    [No Abstract]   [Full Text] [Related]  

  • 38. [SV40 as a possible cofactor in the etiopathogenesis of mesothelioma and other human tumors].
    Barbanti-Brodano G; Trabanelli C; Lazzarin L; Martini F; Merlin M; Calza N; Corallini A; Tognon M
    G Ital Med Lav Ergon; 1998; 20(4):218-24. PubMed ID: 9987613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New developments about the association of SV40 with human mesothelioma.
    Carbone M; Pass HI; Miele L; Bocchetta M
    Oncogene; 2003 Aug; 22(33):5173-80. PubMed ID: 12910254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examination of poliovaccines for the presence of SV40 sequences.
    Sangar DV; Wood DJ; Minor PD
    Dev Biol Stand; 1998; 94():221-5. PubMed ID: 9776243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.